| 1 | [SID14742704] | Active | Potency | 7.0795 | Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1463, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1463 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID14742704] | Active | Potency | 7.9433 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 3 | [SID14742704] | Active | Potency | 7.9433 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 4 | [SID14742704] | Active | IC50 | 9.5 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | IC50 | 9.5 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 5 | [SID14742704] | Active | Potency | 14.1254 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 6 | [SID14742704] | Active | Potency | 14.1254 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 7 | [SID14742704] | Active | IC50 | 14.84 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme [AID624351, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | IC50 | 14.84 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme | | AID | 624351 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID14742704] | Active | Potency | 35.4813 | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 9 | [SID14742704] | Active | Potency | 35.4813 | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 10 | [SID14742704] | Active | Potency | 35.4813 | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 11 | [SID14742704] | Active | Potency | 44.6684 | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 12 | [SID14742704] | Active | Potency | 44.6684 | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 13 | [SID14742704] | Active | Potency | 44.6684 | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 14 | [SID14742704] | Active | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 15 | [SID14742704] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 16 | [SID14742704] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 17 | [SID14742704] | Active | | | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen [AID449739, Type: screening] | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen | | AID | 449739 | | BioAssay type | screening | | Target | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] | | PubMed | | | Data Table |  |
|
| 18 | [SID14742704] | Active | | | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen [AID449739, Type: screening] | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen | | AID | 449739 | | BioAssay type | screening | | Target | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] | | PubMed | | | Data Table |  |
|
| 19 | [SID14742704] | Active | | | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen [AID449739, Type: screening] | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen | | AID | 449739 | | BioAssay type | screening | | Target | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] | | PubMed | | | Data Table |  |
|
| 20 | [SID14742704] | Active | | | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) [AID880, Type: confirmatory] | RGS12 [Homo sapiens] [gi:3290016] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) | | AID | 880 | | BioAssay type | confirmatory | | Target | RGS12 [Homo sapiens] [gi:3290016] | | PubMed | | | Data Table |  |
|
| 21 | [SID14742704] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 22 | [SID14742704] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 23 | [SID14742704] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 24 | [SID14742704] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 25 | [SID14742704] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 26 | [SID14742704] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID540248, Type: other] | HTRA1 protein [gi:121945198] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 540248 | | BioAssay type | other | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 27 | [SID14742704] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 28 | [SID14742704] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 29 | [SID14742704] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 30 | [SID14742704] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 31 | [SID14742704] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 32 | [SID14742704] | Active | | | Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition [AID1481, Type: screening] | Valosin-containing protein [Homo sapiens] [gi:111305821] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition | | AID | 1481 | | BioAssay type | screening | | Target | Valosin-containing protein [Homo sapiens] [gi:111305821] | | PubMed | | | Data Table |  |
|
| 33 | [SID14742704] | Active | | | Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition [AID1481, Type: screening] | Valosin-containing protein [Homo sapiens] [gi:111305821] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition | | AID | 1481 | | BioAssay type | screening | | Target | Valosin-containing protein [Homo sapiens] [gi:111305821] | | PubMed | | | Data Table |  |
|
| 34 | [SID14742704] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2174 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 35 | [SID14742704] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2174 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 36 | [SID14742704] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 37 | [SID14742704] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 38 | [SID14742704] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. [AID2280, Type: screening] | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. | | AID | 2280 | | BioAssay type | screening | | Target | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] | | PubMed | | | Data Table |  |
|
| 39 | [SID14742704] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). [AID2130, Type: screening] | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). | | AID | 2130 | | BioAssay type | screening | | Target | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] | | PubMed | | | Data Table |  |
|
| 40 | [SID14742704] | Active | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) [AID2012, Type: confirmatory] | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) | | AID | 2012 | | BioAssay type | confirmatory | | Target | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] | | PubMed | | | Data Table |  |
|
| 41 | [SID14742704] | Active | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP) [AID2014, Type: confirmatory] | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP) | | AID | 2014 | | BioAssay type | confirmatory | | Target | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] | | PubMed | | | Data Table |  |
|
| 42 | [SID14742704] | Active | | | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) [AID602440, Type: screening] | SENP8 gene product [Homo sapiens] [gi:262118306] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) | | AID | 602440 | | BioAssay type | screening | | Target | SENP8 gene product [Homo sapiens] [gi:262118306] | | PubMed | | | Data Table |  |
|
| 43 | [SID14742704] | Active | | | Screen for Chemicals that Extend Yeast Lifespan [AID775, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Screen for Chemicals that Extend Yeast Lifespan | | AID | 775 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID14742704] | Active | | | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen [AID598, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen | | AID | 598 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID14742704] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652017, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652017 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID14742704] | Active | | | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease [AID624483, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease | | AID | 624483 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID14742704] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2177, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2177 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 48 | [SID14742704] | Active | | | Screen for Chemicals that Extend Yeast Lifespan, Dose Response [AID809, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Screen for Chemicals that Extend Yeast Lifespan, Dose Response | | AID | 809 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID14742704] | Active | | | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID624204, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 624204 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 50 | [SID14742704] | Active | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 14742704 | | CID | 5904397 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|